PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+29.36%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$3.44B
AUM Growth
+$3.44B
(+8.1%)
Cap. Flow
+$258M
Cap. Flow
% of AUM
7.49%
Top 10 Holdings %
Top 10 Hldgs %
43.94%
Holding
127
New
15
Increased
25
Reduced
25
Closed
9
Top Buys
| 1 |
Relmada Therapeutics
RLMD
|
$83.7M |
| 2 |
Amylyx Pharmaceuticals
AMLX
|
$54.4M |
| 3 |
BLU
BELLUS Health Inc.
BLU
|
$49.8M |
| 4 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$40.3M |
| 5 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$32.4M |
Top Sells
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$47.2M |
| 2 |
Eli Lilly
LLY
|
$32.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
$31.6M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$25.2M |
| 5 |
Procept Biorobotics
PRCT
|
$20.1M |
Sector Composition
| 1 | Healthcare | 97.83% |
| 2 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amicus Therapeutics
FOLD
$2.34B
| $286M | 8.29% | 27,372,917 +477,385 | +2% | +$4.98M |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $194M | 5.64% | 2,784,796 -82,067 | -3% | -$5.73M |
|
|
CERE
3
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $184M | 5.34% | 6,511,727 +1,425,000 | +28% | +$40.3M |
|
|
GBT
4
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $158M | 4.59% | 2,322,247 -692,807 | -23% | -$47.2M |
|
|
5
Amylyx Pharmaceuticals
AMLX
$836M
| $154M | 4.47% | 5,472,033 +1,931,625 | +55% | +$54.4M |
|
|
LIAN
6
DELISTED
LianBio American Depositary Shares
LIAN
| $115M | 3.34% | 57,558,451 +998,240 | +2% | +$2M |
|
|
CINC
7
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $109M | 3.15% | 3,306,649 +987,532 | +43% | +$32.4M |
|
|
BLU
8
DELISTED
BELLUS Health Inc.
BLU
| $108M | 3.14% | 10,247,073 +4,712,904 | +85% | +$49.8M |
|
9
Crinetics Pharmaceuticals
CRNX
$2.92B
| $105M | 3.03% | 5,321,032 | – | – |
|
|
SWTX
10
DELISTED
SpringWorks Therapeutics
SWTX
| $99M | 2.87% | 3,470,563 -396,883 | -10% | -$11.3M |
|
11
Iovance Biotherapeutics
IOVA
$807M
| $98.2M | 2.85% | 10,248,624 -1,577,675 | -13% | -$15.1M |
|
|
12
Relmada Therapeutics
RLMD
$37.2M
| $88.2M | 2.56% | 2,383,478 +2,262,128 | +1,864% | +$83.7M |
|
|
RXDX
13
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $86.7M | 2.52% | 1,468,512 -213,730 | -13% | -$12.6M |
|
14
Xenon Pharmaceuticals
XENE
$2.98B
| $76.6M | 2.22% | 2,122,535 | – | – |
|
15
Aldeyra Therapeutics
ALDX
$351M
| $60.6M | 1.76% | 11,350,085 +1,446,206 | +15% | +$7.72M |
|
16
MeiraGTx Holdings
MGTX
$587M
| $58.6M | 1.7% | 6,963,277 | – | – |
|
|
INBX
17
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $51.8M | 1.5% | 2,887,860 +973,268 | +51% | +$17.5M |
|
|
VRNA
18
Verona Pharma
VRNA
$9.16B
| $51.6M | 1.5% | 5,047,264 +2,132,118 | +73% | +$21.8M |
|
19
Cogent Biosciences
COGT
$1.69B
| $47.9M | 1.39% | 3,207,441 +118,469 | +4% | +$1.77M |
|
20
Arcellx
ACLX
$3.85B
| $46.3M | 1.34% | 2,465,405 +1,323,415 | +116% | +$24.8M |
|
21
Lyra Therapeutics
LYRA
$11.5M
| $45.8M | 1.33% | 9,146,730 | – | – |
|
|
ALBO
22
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $45.7M | 1.33% | 2,360,139 | – | – |
|
23
Veru
VERU
$47.6M
| $44.8M | 1.3% | 3,893,000 +393,000 | +11% | +$4.53M |
|
24
Relay Therapeutics
RLAY
$619M
| $43.5M | 1.26% | 1,943,097 | – | – |
|
|
SGEN
25
DELISTED
Seagen Inc. Common Stock
SGEN
| $43.3M | 1.26% | 316,544 +92,544 | +41% | +$12.7M |
|